معرفی
George Tan is a Research Fellow in Pharmacoepidemiology and Real-world Evidence at the Centre for Medicine Use and Safety and an Assistant Lecturer at the Faculty of Pharmacy and Pharmaceutical Sciences, Monash University. He is actively engaged in research and teaching, with a focus on medication safety, real-world evidence, and diabetes pharmacotherapy.
Education:
- PhD in Pharmacoepidemiology, Centre for Medicine Use and Safety, Monash University (2025)
- BPharm (Hons) in Pharmacy, Monash University
His research interests lie at the intersection of pharmacoepidemiology, drug repurposing, and population health. He utilizes large-scale registry and real-world data to investigate medication use patterns and clinical outcomes, particularly in diabetes and cardiovascular disease. His work contributes to evidence-based medicine and aligns with UN Sustainable Development Goals in health and education.
His recent publications demonstrate a strong focus on SGLT-2 inhibitors, COX-2 inhibitors, and real-world outcomes in type 2 diabetes, employing advanced epidemiological methods such as outcome-wide association studies and population-based cohort designs. He also contributes to pharmacy education research, particularly in clinical assessment and student performance.
Scientific Awards:
- Pharmacy Gold Medal and Neil Naismith Award (2019)
- Postgraduate Publication Award (2024)
- PharmAlliance Early-Career Researcher Award (2025)
George Tan advises PhD students and is actively involved in teaching undergraduate and postgraduate courses in Medication Safety and Evidence-based Practice. He coordinates Objective Structured Clinical Examinations (OSCEs), contributing significantly to clinical training. His research is supported by institutional and collaborative grants, though specific funding sources are not detailed in the text. He is also a practicing pharmacist with experience in both community and hospital settings, enhancing the translational impact of his academic work.
He is affiliated with the Centre for Medicine Use and Safety, a research hub focused on optimizing medication use and improving patient outcomes through evidence generation and education.
